Luigi Sinigaglia Selected Research

Luigi Sinigaglia Research Topics

Disease

20	Rheumatoid Arthritis 01/2022 - 01/2002
3	Reflex Sympathetic Dystrophy (Reflex Sympathetic Dystrophy Syndrome) 01/2017 - 03/2013
3	Pain (Aches) 07/2014 - 01/2010
3	Osteoporosis 09/2007 - 07/2004
2	Overweight 04/2021 - 09/2007
2	Adult-Onset Still's Disease 01/2020 - 12/2019
2	Synovitis 01/2020 - 09/2002
2	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 12/2019 - 11/2019
2	Body Weight (Weight, Body) 09/2007 - 05/2003
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	COVID-19 01/2022
1	Chronic Pain 01/2020
1	Edema (Dropsy) 01/2020
1	Inflammation (Inflammations) 01/2020
1	Antisynthetase syndrome 11/2019
1	Arthritis (Polyarthritis) 11/2019
1	Myositis (Idiopathic Inflammatory Myopathies) 11/2019
1	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2019
1	Necrosis 01/2019
1	Psoriatic Arthritis 09/2017
1	Ankylosing Spondylitis 09/2017
1	Spondylitis 05/2015
1	Bone Diseases (Bone Disease) 07/2014
1	Angiomatosis 11/2013
1	Lupus Nephritis 10/2012
1	Back Pain (Backache) 01/2010
1	Vitamin D Deficiency 01/2010
1	Iron Overload 01/2008
1	Joint Diseases (Joint Disease) 01/2008
1	Alcoholism (Alcohol Abuse) 01/2008
1	Bone Resorption 01/2007
1	Neoplasms (Cancer) 03/2006
1	Muscular Diseases (Myopathy) 03/2006
1	Vipoma (WDHA) 03/2006
1	Islet Cell Adenoma (Islet Cell Tumors) 03/2006

Drug/Important Bio-Agent (IBA)

4	Methotrexate (Mexate)FDA LinkGeneric 04/2021 - 09/2002
4	Adalimumab (Humira)FDA Link 01/2020 - 11/2013
3	Vitamin D FDA LinkGeneric 01/2022 - 01/2010
3	Interleukin-1 (Interleukin 1)IBA 01/2020 - 01/2019
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2017 - 01/2002
3	Diphosphonates (Bisphosphonates)IBA 01/2017 - 01/2007
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 11/2013
2	tocilizumab (atlizumab)FDA Link 01/2020 - 03/2019
2	CytokinesIBA 07/2019 - 11/2013
2	Tumor Necrosis Factor InhibitorsIBA 01/2019 - 02/2018
2	golimumab FDA Link 02/2018 - 09/2017
2	Etanercept (Enbrel)FDA Link 02/2018 - 11/2013
2	Alkaline PhosphataseIBA 11/2013 - 01/2010
2	CalciumIBA 09/2007 - 05/2003
1	Antirheumatic Agents (DMARD)IBA 01/2020
1	GadoliniumIBA 01/2020
1	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 11/2019
1	AntibodiesIBA 11/2019
1	AutoantibodiesIBA 11/2019
1	Ligases (Synthetase)IBA 11/2019
1	Transfer RNA (tRNA)IBA 11/2019
1	baricitinibIBA 07/2019
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2019
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2019
1	Abatacept (Orencia)FDA Link 09/2017
1	Infliximab (Remicade)FDA Link 11/2013
1	Interleukin-6 (Interleukin 6)IBA 11/2013
1	OsteopontinIBA 11/2013
1	OsteoprotegerinIBA 11/2013
1	6- amino- 1- hydroxyhexane- 1,1- diphosphonateIBA 03/2013
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2012
1	Rituximab (Mabthera)FDA Link 10/2012
1	25-hydroxyvitamin DIBA 01/2010
1	hydroxide ionIBA 01/2010
1	Ferritins (Ferritin)IBA 01/2008
1	Transferrin (beta 2 Transferrin)IBA 01/2008
1	IronIBA 01/2008
1	Dietary CalciumIBA 09/2007
1	Raloxifene Hydrochloride (Evista)FDA Link 10/2006
1	Risedronic Acid (Actonel)FDA LinkGeneric 10/2006
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 10/2006
1	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 03/2006
1	Pancreatic Polypeptide (Pancreatic Polypeptide (PP))IBA 03/2006
1	PotassiumIBA 03/2006
1	ametantrone (HAQ)IBA 07/2004

Therapy/Procedure

4	Therapeutics 04/2021 - 09/2002
3	Biological Therapy 03/2021 - 05/2011
1	Precision Medicine 01/2020
1	Drug Tapering 01/2020
1	Transitional Care 11/2019
1	Drug Therapy (Chemotherapy) 10/2006